A randomized phase III trial of paclitaxel with or without bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: Eastern cooperative oncology group trial E2100
Open Access
- 1 March 2006
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 4 (2) , 47
- https://doi.org/10.1016/s1359-6349(06)80030-3
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: